These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30716598)

  • 1. Randomized controlled trial of cognitive-motivational therapy program (PIPE) for the initial phase of schizophrenia: Maintenance of efficacy at 5-year follow up
    Palma C; Farriols N; Frías A; Cañete J; Gomis O; Fernández M; Alonso I; Signo S
    Psychiatry Res; 2019 Mar; 273():586-594. PubMed ID: 30716598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.
    Chien WT; Mui JH; Cheung EF; Gray R
    Trials; 2015 Jun; 16():270. PubMed ID: 26072311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial.
    Smeerdijk M; Keet R; Dekker N; van Raaij B; Krikke M; Koeter M; de Haan L; Barrowclough C; Schippers G; Linszen D
    Psychol Med; 2012 Aug; 42(8):1627-36. PubMed ID: 22152121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivational interviewing and interaction skills training for parents of young adults with recent-onset schizophrenia and co-occurring cannabis use: 15-month follow-up.
    Smeerdijk M; Keet R; van Raaij B; Koeter M; Linszen D; de Haan L; Schippers G
    Psychol Med; 2015 Oct; 45(13):2839-48. PubMed ID: 25959502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial.
    Langer ÁI; Schmidt C; Mayol R; Díaz M; Lecaros J; Krogh E; Pardow A; Vergara C; Vergara G; Pérez-Herrera B; Villar MJ; Maturana A; Gaspar PA
    Trials; 2017 May; 18(1):233. PubMed ID: 28545578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT.
    Reddy LF; Glynn SM; McGovern JE; Sugar CA; Reavis EA; Green MF
    Am J Psychiatry; 2023 May; 180(5):367-376. PubMed ID: 36891649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of social skills training for patients with treatment-resistant schizophrenia with predominantly negative symptoms.
    Kayo M; Scemes S; Savoia MG; Bichuette A; Abreu AC; da Silva EP; Baria P; Piovaccari V; Petreche B; Bressan RA; Gadelha A; Elkis H
    Psychiatry Res; 2020 May; 287():112914. PubMed ID: 32199184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Client interpersonal impacts as mediators of long-term outcome in cognitive-behavioral therapy integrated with motivational interviewing for generalized anxiety disorder.
    Constantino MJ; Romano FM; Coyne AE; Westra HA; Antony MM
    Psychother Res; 2018 Nov; 28(6):861-872. PubMed ID: 28337945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial.
    Rabanea-Souza T; Cirigola SMC; Noto C; Gomes JS; Azevedo CC; Gadelha A; Cordeiro Q; Dias ÁM; Lacerda ALT
    Trials; 2019 Apr; 20(1):199. PubMed ID: 30953544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological therapies for pathological and problem gambling.
    Cowlishaw S; Merkouris S; Dowling N; Anderson C; Jackson A; Thomas S
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008937. PubMed ID: 23152266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who benefits from adolescent sleep interventions? Moderators of treatment efficacy in a randomized controlled trial of a cognitive-behavioral and mindfulness-based group sleep intervention for at-risk adolescents.
    Blake MJ; Blake LM; Schwartz O; Raniti M; Waloszek JM; Murray G; Simmons JG; Landau E; Dahl RE; McMakin DL; Dudgeon P; Trinder J; Allen NB
    J Child Psychol Psychiatry; 2018 Jun; 59(6):637-649. PubMed ID: 29164609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive therapy for schizophrenia: a preliminary randomized controlled trial.
    Rector NA; Seeman MV; Segal ZV
    Schizophr Res; 2003 Sep; 63(1-2):1-11. PubMed ID: 12892853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing assertive community treatment with cognitive behavioral social skills training for schizophrenia: study protocol for a randomized controlled trial.
    Granholm E; Holden JL; Sommerfeld D; Rufener C; Perivoliotis D; Mueser K; Aarons GA
    Trials; 2015 Sep; 16():438. PubMed ID: 26424639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.
    Haddock G; Barrowclough C; Tarrier N; Moring J; O'Brien R; Schofield N; Quinn J; Palmer S; Davies L; Lowens I; McGovern J; Lewis S
    Br J Psychiatry; 2003 Nov; 183():418-26. PubMed ID: 14594917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year follow-up of cognitive--behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia.
    Tarrier N; Kinney C; McCarthy E; Humphreys L; Wittkowski A; Morris J
    J Consult Clin Psychol; 2000 Oct; 68(5):917-22. PubMed ID: 11068978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief telephone interventions for problem gambling: a randomized controlled trial.
    Abbott M; Hodgins DC; Bellringer M; Vandal AC; Palmer Du Preez K; Landon J; Sullivan S; Rodda S; Feigin V
    Addiction; 2018 May; 113(5):883-895. PubMed ID: 29274179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of a randomised clinical trial testing whether metacognitive training can improve insight and clinical outcomes in schizophrenia.
    Lopez-Morinigo JD; Ruiz-Ruano VG; Martínez ASE; Estévez MLB; Mata-Iturralde L; Muñoz-Lorenzo L; Sánchez-Alonso S; Artés-Rodríguez A; David AS; Baca-García E
    BMC Psychiatry; 2020 Jan; 20(1):30. PubMed ID: 31996174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication.
    Sensky T; Turkington D; Kingdon D; Scott JL; Scott J; Siddle R; O'Carroll M; Barnes TR
    Arch Gen Psychiatry; 2000 Feb; 57(2):165-72. PubMed ID: 10665619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.